カテゴリー： Transparency Market Research, 世界, 医療/バイオ

世界の血管グラフト（人工血管）市場2022年ｰ2031年：製品別（血管内ステントグラフト、末梢血管用グラフト、血液透析アクセスグラフト、バイパスグラフト、その他）、ソース別

◆英語タイトル：Vascular Grafts Market (Product: Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, Bypass Graft, and Others; Source: Synthetic, Biological, and Biosynthetic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが発行した調査報告書（TMR23JA104）◆商品コード：TMR23JA104
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2022年11月16日
◆ページ数：283
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社は、世界の血管グラフト（人工血管）市場について調査し、序論、仮定・調査手法、市場概要、主要インサイト、製品別（血管内ステントグラフト、末梢血管用グラフト、血液透析アクセスグラフト、バイパスグラフト、その他）分析、サイズ別（大型、小型）分析、ソース別（合成、生体、生合成）分析、用途別（冠動脈バイパス、動脈瘤、血管閉塞、重症虚血肢、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況、企業情報などの内容を掲載しています。なお、当書に掲載されている企業情報には、B. Braun SE、BD、Cook Medical, Inc.、CryoLife, Inc.、Getinge AB、Heart Medical、JUNKEN MEDICAL Co., Ltd.、LeMaitre Vascular, Inc.、Medtronic、Terumo Corporationなどが含まれています。
・序論
・仮定・調査手法
・市場概要
・主要インサイト

・世界の血管グラフト（人工血管）市場規模：製品別
- 血管内ステントグラフトの市場規模
- 末梢血管用グラフトの市場規模
- 血液透析アクセスグラフトの市場規模
- バイパスグラフトの市場規模
- その他製品の市場規模

・世界の血管グラフト（人工血管）市場規模：サイズ別
- 大型血管グラフト（人工血管）の市場規模
- 小型血管グラフト（人工血管）の市場規模

・世界の血管グラフト（人工血管）市場規模：ソース別
- 合成血管グラフトの市場規模
- 生体血管グラフトの市場規模
- 生合成血管グラフトの市場規模

・世界の血管グラフト（人工血管）市場規模：用途別
- 冠動脈バイパス用血管グラフト（人工血管）の市場規模
- 動脈瘤用血管グラフト（人工血管）の市場規模
- 血管閉塞用血管グラフト（人工血管）の市場規模
- 重症虚血肢用血管グラフト（人工血管）の市場規模
- その他用途の市場規模

・世界の血管グラフト（人工血管）市場規模：地域別
- 北米の血管グラフト（人工血管）市場規模
- ヨーロッパの血管グラフト（人工血管）市場規模
- アジア太平洋の血管グラフト（人工血管）市場規模
- 中南米の血管グラフト（人工血管）市場規模
- 中東/アフリカの血管グラフト（人工血管）市場規模

・競争状況
・企業情報

Vascular Grafts Market – Scope of Report
TMR’s report on the global vascular grafts market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vascular grafts market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vascular grafts market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vascular grafts market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vascular grafts market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global vascular grafts market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vascular grafts market.

The report delves into the competitive landscape of the global vascular grafts market. Key players operating in the global vascular grafts market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vascular grafts market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market vascular grafts.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vascular Grafts Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vascular Grafts Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Global Prevalence of Chronic Kidney Diseases
5.3. Global Prevalence of Cardiovascular Diseases
5.4. Covid-19 Pandemic Impact on the Industry
6. Global Vascular Grafts Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Endovascular Stent Graft
6.3.2. Peripheral Vascular Graft
6.3.3. Hemodialysis Access Graft
6.3.4. Bypass Graft
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
7.3.1. Large Size Vascular Graft
7.3.2. Small Size Vascular Graft
7.4. Market Attractiveness Analysis, by Size of Vascular Graft
8. Global Vascular Grafts Market Analysis and Forecast, by Source
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Source, 2017–2031
8.3.1. Synthetic
8.3.1.1. Polytetrafluethylene (PTFE)
8.3.1.2. Polyurethane (PU)
8.3.1.3. Dacron
8.3.1.4. Others
8.3.2. Biological
8.3.2.1. Bovine Vein
8.3.2.2. Saphenous Vein
8.3.2.3. Others
8.3.3. Biosynthetic
8.3.3.1. Ovine Collagen with Polyester
8.3.3.2. Others
8.4. Market Attractiveness Analysis, by Source
9. Global Vascular Grafts Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Coronary Artery Bypass
9.3.2. Aneurysm
9.3.3. Vascular Occlusion
9.3.4. Critical Limb Ischemia
9.3.5. Renal Failure
9.3.6. Others
9.4. Market Attractiveness Analysis, by Application
10. Global Vascular Grafts Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgery Centers
10.3.3. Cardiac Catheterization Laboratories
10.3.4. Specialty Clinics
10.3.5. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Vascular Grafts Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Vascular Grafts Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Endovascular Stent Graft
12.2.2. Peripheral Vascular Graft
12.2.3. Hemodialysis Access Graft
12.2.4. Bypass Graft
12.2.5. Others
12.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
12.3.1. Large Size Vascular Graft
12.3.2. Small Size Vascular Graft
12.4. Market Value Forecast, by Source, 2017–2031
12.4.1. Synthetic
12.4.1.1. Polytetrafluethylene (PTFE)
12.4.1.2. Polyurethane (PU)
12.4.1.3. Dacron
12.4.1.4. Others
12.4.2. Biological
12.4.2.1. Bovine Vein
12.4.2.2. Saphenous Vein
12.4.2.3. Others
12.4.3. Biosynthetic
12.4.3.1. Ovine Collagen with Polyester
12.4.3.2. Others
12.5. Market Value Forecast, by Application , 2017–2031
12.5.1. Coronary Artery Bypass
12.5.2. Aneurysm
12.5.3. Vascular Occlusion
12.5.4. Critical Limb Ischemia
12.5.5. Renal Failure
12.5.6. Others
12.6. Market Value Forecast, by End-user, 2017–2031
12.6.1. Hospitals
12.6.2. Ambulatory Surgery Centers
12.6.3. Cardiac Catheterization Laboratories
12.6.4. Specialty Clinics
12.6.5. Others
12.7. Market Value Forecast, by Country, 2017–2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Product
12.8.2. By Size of Vascular Graft
12.8.3. By Source
12.8.4. By Application
12.8.5. By End-user
12.8.6. By Country
13. Europe Vascular Grafts Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Endovascular Stent Graft
13.2.2. Peripheral Vascular Graft
13.2.3. Hemodialysis Access Graft
13.2.4. Bypass Graft
13.2.5. Others
13.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
13.3.1. Large Size Vascular Graft
13.3.2. Small Size Vascular Graft
13.4. Market Value Forecast, by Source, 2017–2031
13.4.1. Synthetic
13.4.1.1. Polytetrafluethylene (PTFE)
13.4.1.2. Polyurethane (PU)
13.4.1.3. Dacron
13.4.1.4. Others
13.4.2. Biological
13.4.2.1. Bovine Vein
13.4.2.2. Saphenous Vein
13.4.2.3. Others
13.4.3. Biosynthetic
13.4.3.1. Ovine Collagen with Polyester
13.4.3.2. Others
13.5. Market Value Forecast, by Application, 2017–2031
13.5.1. Coronary Artery Bypass
13.5.2. Aneurysm
13.5.3. Vascular Occlusion
13.5.4. Critical Limb Ischemia
13.5.5. Renal Failure
13.5.6. Others
13.6. Market Value Forecast, by End-user, 2017–2031
13.6.1. Hospitals
13.6.2. Ambulatory Surgery Centers
13.6.3. Cardiac Catheterization Laboratories
13.6.4. Specialty Clinics
13.6.5. Others
13.7. Market Value Forecast, by Country/Sub-region, 2017–2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Product
13.8.2. By Size of Vascular Graft
13.8.3. By Source
13.8.4. By Application
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Vascular Grafts Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Endovascular Stent Graft
14.2.2. Peripheral Vascular Graft
14.2.3. Hemodialysis Access Graft
14.2.4. Bypass Graft
14.2.5. Others
14.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
14.3.1. Large Size Vascular Graft
14.3.2. Small Size Vascular Graft
14.4. Market Value Forecast, by Source, 2017–2031
14.4.1. Synthetic
14.4.1.1. Polytetrafluethylene (PTFE)
14.4.1.2. Polyurethane (PU)
14.4.1.3. Dacron
14.4.1.4. Others
14.4.2. Biological
14.4.2.1. Bovine Vein
14.4.2.2. Saphenous Vein
14.4.2.3. Others
14.4.3. Biosynthetic
14.4.3.1. Ovine Collagen with Polyester
14.4.3.2. Others
14.5. Market Value Forecast, by Application, 2017–2031
14.5.1. Coronary Artery Bypass
14.5.2. Aneurysm
14.5.3. Vascular Occlusion
14.5.4. Critical Limb Ischemia
14.5.5. Renal Failure
14.5.6. Others
14.6. Market Value Forecast, by End-user, 2017–2031
14.6.1. Hospitals
14.6.2. Ambulatory Surgery Centers
14.6.3. Cardiac Catheterization Laboratories
14.6.4. Specialty Clinics
14.6.5. Others
14.7. Market Value Forecast, by Country/Sub-region, 2017–2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Product
14.8.2. By Size of Vascular Graft
14.8.3. By Source
14.8.4. By Application
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Vascular Grafts Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Endovascular Stent Graft
15.2.2. Peripheral Vascular Graft
15.2.3. Hemodialysis Access Graft
15.2.4. Bypass Graft
15.2.5. Others
15.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
15.3.1. Large Size Vascular Graft
15.3.2. Small Size Vascular Graft
15.4. Market Value Forecast, by Source, 2017–2031
15.4.1. Synthetic
15.4.1.1. Polytetrafluethylene (PTFE)
15.4.1.2. Polyurethane (PU)
15.4.1.3. Dacron
15.4.1.4. Others
15.4.2. Biological
15.4.2.1. Bovine Vein
15.4.2.2. Saphenous Vein
15.4.2.3. Others
15.4.3. Biosynthetic
15.4.3.1. Ovine Collagen with Polyester
15.4.3.2. Others
15.5. Market Value Forecast, by Application , 2017–2031
15.5.1. Coronary Artery Bypass
15.5.2. Aneurysm
15.5.3. Vascular Occlusion
15.5.4. Critical Limb Ischemia
15.5.5. Renal Failure
15.5.6. Others
15.6. Market Value Forecast, by End-user, 2017–2031
15.6.1. Hospitals
15.6.2. Ambulatory Surgery Centers
15.6.3. Cardiac Catheterization Laboratories
15.6.4. Specialty Clinics
15.6.5. Others
15.7. Market Value Forecast, by Country/Sub-region, 2017–2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Product
15.8.2. By Size of Vascular Graft
15.8.3. By Source
15.8.4. By Application
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Vascular Grafts Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2017–2031
16.2.1. Endovascular Stent Graft
16.2.2. Peripheral Vascular Graft
16.2.3. Hemodialysis Access Graft
16.2.4. Bypass Graft
16.2.5. Others
16.3. Market Value Forecast, by Size of Vascular Graft, 2017–2031
16.3.1. Large Size Vascular Graft
16.3.2. Small Size Vascular Graft
16.4. Market Value Forecast, by Source, 2017–2031
16.4.1. Synthetic
16.4.1.1. Polytetrafluethylene (PTFE)
16.4.1.2. Polyurethane (PU)
16.4.1.3. Dacron
16.4.1.4. Others
16.4.2. Biological
16.4.2.1. Bovine Vein
16.4.2.2. Saphenous Vein
16.4.2.3. Others
16.4.3. Biosynthetic
16.4.3.1. Ovine Collagen with Polyester
16.4.3.2. Others
16.5. Market Value Forecast, by Application, 2017–2031
16.5.1. Coronary Artery Bypass
16.5.2. Aneurysm
16.5.3. Vascular Occlusion
16.5.4. Critical Limb Ischemia
16.5.5. Renal Failure
16.5.6. Others
16.6. Market Value Forecast, by End-user, 2017–2031
16.6.1. Hospitals
16.6.2. Ambulatory Surgery Centers
16.6.3. Cardiac Catheterization Laboratories
16.6.4. Specialty Clinics
16.6.5. Others
16.7. Market Value Forecast, by Country/Sub-region, 2017–2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Product
16.8.2. By Size of Vascular Graft
16.8.3. By Source
16.8.4. By Application
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company, 2021
17.3. Company Profiles
17.3.1. B. Braun SE
17.3.1.1. Company Overview
17.3.1.2. Product Portfolio
17.3.1.3. SWOT Analysis
17.3.1.4. Strategic Overview
17.3.2. BD
17.3.2.1. Company Overview
17.3.2.2. Product Portfolio
17.3.2.3. SWOT Analysis
17.3.2.4. Strategic Overview
17.3.3. Cook Medical, Inc.
17.3.3.1. Company Overview
17.3.3.2. Product Portfolio
17.3.3.3. SWOT Analysis
17.3.3.4. Strategic Overview
17.3.4. CryoLife, Inc.
17.3.4.1. Company Overview
17.3.4.2. Product Portfolio
17.3.4.3. SWOT Analysis
17.3.4.4. Strategic Overview
17.3.5. Getinge AB
17.3.5.1. Company Overview
17.3.5.2. Product Portfolio
17.3.5.3. SWOT Analysis
17.3.5.4. Strategic Overview
17.3.6. Heart Medical
17.3.6.1. Company Overview
17.3.6.2. Product Portfolio
17.3.6.3. SWOT Analysis
17.3.6.4. Strategic Overview
17.3.7. JUNKEN MEDICAL Co., Ltd.
17.3.7.1. Company Overview
17.3.7.2. Product Portfolio
17.3.7.3. SWOT Analysis
17.3.7.4. Strategic Overview
17.3.8. LeMaitre Vascular, Inc.
17.3.8.1. Company Overview
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.8.4. Strategic Overview
17.3.9. Medtronic
17.3.9.1. Company Overview
17.3.9.2. Product Portfolio
17.3.9.3. SWOT Analysis
17.3.9.4. Strategic Overview
17.3.10. Terumo Corporation
17.3.10.1. Company Overview
17.3.10.2. Product Portfolio
17.3.10.3. SWOT Analysis
17.3.10.4. Strategic Overview
17.3.11. Vascular Graft Solutions
17.3.11.1. Company Overview
17.3.11.2. Product Portfolio
17.3.11.3. SWOT Analysis
17.3.11.4. Strategic Overview
17.3.12. W. L. Gore & Associates, Inc.
17.3.12.1. Company Overview
17.3.12.2. Product Portfolio
17.3.12.3. SWOT Analysis
17.3.12.4. Strategic Overview



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の血管グラフト（人工血管）市場2022年ｰ2031年：製品別（血管内ステントグラフト、末梢血管用グラフト、血液透析アクセスグラフト、バイパスグラフト、その他）、ソース別(Vascular Grafts Market (Product: Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, Bypass Graft, and Others; Source: Synthetic, Biological, and Biosynthetic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の経口補水液（ORS）市場2022年ｰ2031年：物販別（OTC製品、処方箋）、剤形別

    • ◆H&Iグローバルリサーチのお客様（例）◆